"10.1371_journal.pgen.1000504","plos genetics","2009-06-05T00:00:00Z","Melanie Kolz; Toby Johnson; Serena Sanna; Alexander Teumer; Veronique Vitart; Markus Perola; Massimo Mangino; Eva Albrecht; Chris Wallace; Martin Farrall; Åsa Johansson; Dale R Nyholt; Yurii Aulchenko; Jacques S Beckmann; Sven Bergmann; Murielle Bochud; Morris Brown; Harry Campbell; for the EUROSPAN Consortium; John Connell; Anna Dominiczak; Georg Homuth; Claudia Lamina; Mark I McCarthy; for the ENGAGE Consortium; Thomas Meitinger; Vincent Mooser; Patricia Munroe; Matthias Nauck; John Peden; Holger Prokisch; Perttu Salo; Veikko Salomaa; Nilesh J Samani; David Schlessinger; Manuela Uda; Uwe Völker; Gérard Waeber; Dawn Waterworth; Rui Wang-Sattler; Alan F Wright; Jerzy Adamski; John B Whitfield; Ulf Gyllensten; James F Wilson; Igor Rudan; Peter Pramstaller; Hugh Watkins; for the PROCARDIS Consortium; Angela Doering; H-Erich Wichmann; for the KORA Study; Tim D Spector; Leena Peltonen; Henry Völzke; Ramaiah Nagaraja; Peter Vollenweider; Mark Caulfield; for the WTCCC; Thomas Illig; Christian Gieger","Institute of Epidemiology, Helmholtz Zentrum München, National Research Center for Environment and Health, Neuherberg, Germany; Department of Medical Genetics, University of Lausanne, Lausanne, Switzerland; Swiss Institute of Bioinformatics, Lausanne, Switzerland; University Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, Switzerland; Istituto di Neurogenetica e Neurofarmacologia, Cagliari, Italy; Interfaculty Institute for Genetics and Functional Genomics, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany; MRC Human Genetics Unit, IGMM, Western General Hospital, Crewe Road, Edinburgh, United Kingdom; Department of Chronic Disease Prevention, Institute of Health and Welfare, Helsinki, Finland; FIMM, Institute of Molecular Medicine, Helsinki, Finland; DTR Department of Twin Research and Genetic Epidemiology, Kings College London, London, United Kingdom; The Diabetes Inflammation Laboratory, Cambridge Institute of Medical Research, Cambridge University, Cambridge, United Kingdom; Department of Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom; The Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, United Kingdom; Department of Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden; Genetic Epidemiology Unit, Queensland Institute of Medical Research, Brisbane, Australia; Department of Epidemiology, Erasmus MC Rotterdam, Rotterdam, The Netherlands; Service of Medical Genetics, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Clinical Pharmacology Unit, Addenbrookes Hospital, University of Cambridge, Cambridge, United Kingdom; Centre for Population Health Sciences, University of Edinburgh, Edinburgh, United Kingdom; Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom; Division of Genetic Epidemiology, Department of Medical Genetics, Molecular and Clinical Pharmacology, Innsbruck Medical University, Innsbruck, Austria; Oxford Centre for Diabetes, Endocrinology and Metabolism, University of Oxford, Churchill Hospital, Oxford, United Kingdom; National Institute for Health Research, Oxford Biomedical Research Centre, University of Oxford, Headington, Oxford, United Kingdom; Institute of Human Genetics, Helmholtz Zentrum München, National Research Center for Environment and Health, Neuherberg, Germany; Genetics Division, GlaxoSmithKline, King of Prussia, Pennsylvania, United States of America; The William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, England; Institut für Klinische Chemie und Laboratoriumsmedizin, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany; Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, United Kingdom; Laboratory of Genetics, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, United States of America; Department of Medicine and Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; Genome Analysis Centre, Institute for Experimental Genetics, Helmholtz Zentrum München, National Research Center for Environment and Health, Neuherberg, Germany; Croatian Centre for Global Health, Faculty of Medicine, University of Split, Split, Croatia; Gen-Info, Zagreb, Croatia; Institute of Genetic Medicine, European Academy Bozen/Bolzano (EURAC), Bolzano, Italy; Affiliated Institute of the University Lübeck, Department of Neurology, Central Hospital, Bolzano, Italy; IBE, Chair of Epidemiology, University of Munich, Germany; The Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge, United Kingdom; Institute for Community Medicine, Ernst-Moritz-Arndt-Universität Greifswald, Greifswald, Germany","Conceived and designed the experiments: AFW JA JBW UG JFW IR PP HW AD HEW TDS LP HV RN PV MC TI CG. Performed the experiments: HP RWS. Analyzed the data: MK TJ SS AT VV MP MM EA CW MF ÅJ DRN YA CL PS RWS CG. Contributed reagents/materials/analysis tools: JSB SB MB MB HC JC AD GH MIM TM VM PM MN JP VS NJS DS MU UV GW DW TI. Wrote the paper: MK TJ CG. Conducted meta-analysis: MK TJ EA CG.","Vincent Mooser and Dawn Waterworth are full-time employees of GlaxoSmithKline, a pharmaceutical company. Peter Vollenweider and Gerard Waeber received financial support from GlaxoSmithKline to build the CoLaus study.","2009","06","Melanie Kolz","MK",61,TRUE,18,2,17,3,TRUE,TRUE,TRUE,2,"52;59",TRUE
